Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients

A pilot study

Darius G. Nabavi, Dirk W. Droste, V. Kemény, Gernot Schulte-Altedorneburg, Sepp Weber, E. Bernd Ringelstein

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Background and Purpose - Ultrasonography (US) is a well-established method used to assess the brain-supplying arteries in the acute stroke setting. However, several technical and anatomic limitations are known to reduce its diagnostic accuracy and confidence level. Echocontrast agents (ECA) are known to improve the signal-to-noise ratio by enhancing the intensity of the reflecting Doppler signal. We undertook this prospective study to evaluate the diagnostic value of ECA in a consecutive, nonselected cohort of acute stroke patients with insufficient native US investigations. Methods - During a 1-year period, 25 patients were examined within 48 hours of the onset of stroke. The need for ECA was due to an insufficient transtemporal (n = 18), transforaminal (n = 4), or extracranial (n = 3) imaging of arteries potentially involved in the ischemic event. In 12 patients, a diagnostic suspicion could natively be raised, whereas in the other 13 patients, the strongly reduced image quality did not allow for any neurovascular conclusions. Four grams of Levovist was injected at a concentration of 200 mg/mL and 400 mg/mL for the extracranial and transcranial insonations, respectively. The effect of the echocontrast enhancement was assessed with respect to (1) signal enhancement, (2) image quality, (3) final diagnostic confidence, and (4) the need for additional neurovascular imaging methods. Results - In all but one patient (96%), a strong signal enhancement was noted, leading to a moderate (n = 11) or strong improvement (n = 10) of the transcranial image quality. Thus in a total of 18 patients (72%), the echoenhancement provided a neurovascular diagnosis of sufficient confidence. This led to the confirmation of the previously suspected findings and disclosed three further occlusions and four stenoses of the intracranial arteries. In contrast, for the three extracranial examinations the image quality was not sufficiently improved because of persistent color artifacts derived from adjacent neck vessels. Besides the seven patients with inconclusive examinations, five patients with conclusive echoenhanced US studies (48% in total) demanded additive neurovascular imaging studies, based on the clinical decision of the attending physicians. This led to confirmation of all high-confident sonographic diagnoses. Conclusions - In summary, in approximately three fourths of our acute stroke patients with insufficient native US investigations, echocontrast enhancement enabled a reliable neurovascular diagnosis, allowing the cancellation of additive neurovascular imaging procedures in half of our cohort. Our preliminary results suggest that ECA can reasonably support the early cerebrovascular workup in the acute stroke setting.

Original languageEnglish
Pages (from-to)949-954
Number of pages6
JournalStroke
Volume29
Issue number5
Publication statusPublished - May 1998

Fingerprint

Ultrasonography
Stroke
Arteries
Image Enhancement
Signal-To-Noise Ratio
Artifacts
Pathologic Constriction
Neck
Color
Prospective Studies
Physicians
Brain

Keywords

  • Cerebral arteries
  • Contrast media
  • Stroke
  • Ultrasonics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Nabavi, D. G., Droste, D. W., Kemény, V., Schulte-Altedorneburg, G., Weber, S., & Ringelstein, E. B. (1998). Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: A pilot study. Stroke, 29(5), 949-954.

Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients : A pilot study. / Nabavi, Darius G.; Droste, Dirk W.; Kemény, V.; Schulte-Altedorneburg, Gernot; Weber, Sepp; Ringelstein, E. Bernd.

In: Stroke, Vol. 29, No. 5, 05.1998, p. 949-954.

Research output: Contribution to journalArticle

Nabavi, DG, Droste, DW, Kemény, V, Schulte-Altedorneburg, G, Weber, S & Ringelstein, EB 1998, 'Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: A pilot study', Stroke, vol. 29, no. 5, pp. 949-954.
Nabavi DG, Droste DW, Kemény V, Schulte-Altedorneburg G, Weber S, Ringelstein EB. Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: A pilot study. Stroke. 1998 May;29(5):949-954.
Nabavi, Darius G. ; Droste, Dirk W. ; Kemény, V. ; Schulte-Altedorneburg, Gernot ; Weber, Sepp ; Ringelstein, E. Bernd. / Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients : A pilot study. In: Stroke. 1998 ; Vol. 29, No. 5. pp. 949-954.
@article{93c6ef3e2cf447cfaabe6c58a57aef84,
title = "Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: A pilot study",
abstract = "Background and Purpose - Ultrasonography (US) is a well-established method used to assess the brain-supplying arteries in the acute stroke setting. However, several technical and anatomic limitations are known to reduce its diagnostic accuracy and confidence level. Echocontrast agents (ECA) are known to improve the signal-to-noise ratio by enhancing the intensity of the reflecting Doppler signal. We undertook this prospective study to evaluate the diagnostic value of ECA in a consecutive, nonselected cohort of acute stroke patients with insufficient native US investigations. Methods - During a 1-year period, 25 patients were examined within 48 hours of the onset of stroke. The need for ECA was due to an insufficient transtemporal (n = 18), transforaminal (n = 4), or extracranial (n = 3) imaging of arteries potentially involved in the ischemic event. In 12 patients, a diagnostic suspicion could natively be raised, whereas in the other 13 patients, the strongly reduced image quality did not allow for any neurovascular conclusions. Four grams of Levovist was injected at a concentration of 200 mg/mL and 400 mg/mL for the extracranial and transcranial insonations, respectively. The effect of the echocontrast enhancement was assessed with respect to (1) signal enhancement, (2) image quality, (3) final diagnostic confidence, and (4) the need for additional neurovascular imaging methods. Results - In all but one patient (96{\%}), a strong signal enhancement was noted, leading to a moderate (n = 11) or strong improvement (n = 10) of the transcranial image quality. Thus in a total of 18 patients (72{\%}), the echoenhancement provided a neurovascular diagnosis of sufficient confidence. This led to the confirmation of the previously suspected findings and disclosed three further occlusions and four stenoses of the intracranial arteries. In contrast, for the three extracranial examinations the image quality was not sufficiently improved because of persistent color artifacts derived from adjacent neck vessels. Besides the seven patients with inconclusive examinations, five patients with conclusive echoenhanced US studies (48{\%} in total) demanded additive neurovascular imaging studies, based on the clinical decision of the attending physicians. This led to confirmation of all high-confident sonographic diagnoses. Conclusions - In summary, in approximately three fourths of our acute stroke patients with insufficient native US investigations, echocontrast enhancement enabled a reliable neurovascular diagnosis, allowing the cancellation of additive neurovascular imaging procedures in half of our cohort. Our preliminary results suggest that ECA can reasonably support the early cerebrovascular workup in the acute stroke setting.",
keywords = "Cerebral arteries, Contrast media, Stroke, Ultrasonics",
author = "Nabavi, {Darius G.} and Droste, {Dirk W.} and V. Kem{\'e}ny and Gernot Schulte-Altedorneburg and Sepp Weber and Ringelstein, {E. Bernd}",
year = "1998",
month = "5",
language = "English",
volume = "29",
pages = "949--954",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients

T2 - A pilot study

AU - Nabavi, Darius G.

AU - Droste, Dirk W.

AU - Kemény, V.

AU - Schulte-Altedorneburg, Gernot

AU - Weber, Sepp

AU - Ringelstein, E. Bernd

PY - 1998/5

Y1 - 1998/5

N2 - Background and Purpose - Ultrasonography (US) is a well-established method used to assess the brain-supplying arteries in the acute stroke setting. However, several technical and anatomic limitations are known to reduce its diagnostic accuracy and confidence level. Echocontrast agents (ECA) are known to improve the signal-to-noise ratio by enhancing the intensity of the reflecting Doppler signal. We undertook this prospective study to evaluate the diagnostic value of ECA in a consecutive, nonselected cohort of acute stroke patients with insufficient native US investigations. Methods - During a 1-year period, 25 patients were examined within 48 hours of the onset of stroke. The need for ECA was due to an insufficient transtemporal (n = 18), transforaminal (n = 4), or extracranial (n = 3) imaging of arteries potentially involved in the ischemic event. In 12 patients, a diagnostic suspicion could natively be raised, whereas in the other 13 patients, the strongly reduced image quality did not allow for any neurovascular conclusions. Four grams of Levovist was injected at a concentration of 200 mg/mL and 400 mg/mL for the extracranial and transcranial insonations, respectively. The effect of the echocontrast enhancement was assessed with respect to (1) signal enhancement, (2) image quality, (3) final diagnostic confidence, and (4) the need for additional neurovascular imaging methods. Results - In all but one patient (96%), a strong signal enhancement was noted, leading to a moderate (n = 11) or strong improvement (n = 10) of the transcranial image quality. Thus in a total of 18 patients (72%), the echoenhancement provided a neurovascular diagnosis of sufficient confidence. This led to the confirmation of the previously suspected findings and disclosed three further occlusions and four stenoses of the intracranial arteries. In contrast, for the three extracranial examinations the image quality was not sufficiently improved because of persistent color artifacts derived from adjacent neck vessels. Besides the seven patients with inconclusive examinations, five patients with conclusive echoenhanced US studies (48% in total) demanded additive neurovascular imaging studies, based on the clinical decision of the attending physicians. This led to confirmation of all high-confident sonographic diagnoses. Conclusions - In summary, in approximately three fourths of our acute stroke patients with insufficient native US investigations, echocontrast enhancement enabled a reliable neurovascular diagnosis, allowing the cancellation of additive neurovascular imaging procedures in half of our cohort. Our preliminary results suggest that ECA can reasonably support the early cerebrovascular workup in the acute stroke setting.

AB - Background and Purpose - Ultrasonography (US) is a well-established method used to assess the brain-supplying arteries in the acute stroke setting. However, several technical and anatomic limitations are known to reduce its diagnostic accuracy and confidence level. Echocontrast agents (ECA) are known to improve the signal-to-noise ratio by enhancing the intensity of the reflecting Doppler signal. We undertook this prospective study to evaluate the diagnostic value of ECA in a consecutive, nonselected cohort of acute stroke patients with insufficient native US investigations. Methods - During a 1-year period, 25 patients were examined within 48 hours of the onset of stroke. The need for ECA was due to an insufficient transtemporal (n = 18), transforaminal (n = 4), or extracranial (n = 3) imaging of arteries potentially involved in the ischemic event. In 12 patients, a diagnostic suspicion could natively be raised, whereas in the other 13 patients, the strongly reduced image quality did not allow for any neurovascular conclusions. Four grams of Levovist was injected at a concentration of 200 mg/mL and 400 mg/mL for the extracranial and transcranial insonations, respectively. The effect of the echocontrast enhancement was assessed with respect to (1) signal enhancement, (2) image quality, (3) final diagnostic confidence, and (4) the need for additional neurovascular imaging methods. Results - In all but one patient (96%), a strong signal enhancement was noted, leading to a moderate (n = 11) or strong improvement (n = 10) of the transcranial image quality. Thus in a total of 18 patients (72%), the echoenhancement provided a neurovascular diagnosis of sufficient confidence. This led to the confirmation of the previously suspected findings and disclosed three further occlusions and four stenoses of the intracranial arteries. In contrast, for the three extracranial examinations the image quality was not sufficiently improved because of persistent color artifacts derived from adjacent neck vessels. Besides the seven patients with inconclusive examinations, five patients with conclusive echoenhanced US studies (48% in total) demanded additive neurovascular imaging studies, based on the clinical decision of the attending physicians. This led to confirmation of all high-confident sonographic diagnoses. Conclusions - In summary, in approximately three fourths of our acute stroke patients with insufficient native US investigations, echocontrast enhancement enabled a reliable neurovascular diagnosis, allowing the cancellation of additive neurovascular imaging procedures in half of our cohort. Our preliminary results suggest that ECA can reasonably support the early cerebrovascular workup in the acute stroke setting.

KW - Cerebral arteries

KW - Contrast media

KW - Stroke

KW - Ultrasonics

UR - http://www.scopus.com/inward/record.url?scp=0031960302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031960302&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 949

EP - 954

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 5

ER -